RIGEL PHARMACEUTICALS INC (RIGL) Free cash flow 2016–2022
RIGEL PHARMACEUTICALS INC (RIGL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$74.2MFY2022 · since FY2016: -$76.7M → -$74.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$74.2M | -1513.2% |
| FY2021 | $5.3M | +109.8% |
| FY2020 | -$53.4M | -24.4% |
| FY2019 | -$43.0M | +28.3% |
| FY2018 | -$59.9M | +22.9% |
| FY2017 | -$77.7M | -1.3% |
| FY2016 | -$76.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice